TrialLeukemia2025
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study.
Philippe Moreau et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled ittrialcites it